These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25239189)

  • 41. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.
    Seyfried NT; Gozal YM; Donovan LE; Herskowitz JH; Dammer EB; Xia Q; Ku L; Chang J; Duong DM; Rees HD; Cooper DS; Glass JD; Gearing M; Tansey MG; Lah JJ; Feng Y; Levey AI; Peng J
    J Proteome Res; 2012 May; 11(5):2721-38. PubMed ID: 22416763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.
    Mackenzie IR; Neumann M; Cairns NJ; Munoz DG; Isaacs AM
    J Mol Neurosci; 2011 Nov; 45(3):402-8. PubMed ID: 21603977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.
    Neumann M; Mackenzie IR; Cairns NJ; Boyer PJ; Markesbery WR; Smith CD; Taylor JP; Kretzschmar HA; Kimonis VE; Forman MS
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):152-7. PubMed ID: 17279000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?
    Whitwell JL; Jack CR; Parisi JE; Senjem ML; Knopman DS; Boeve BF; Rademakers R; Baker M; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Dec; 75(24):2212-20. PubMed ID: 21172844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.
    McMillan CT; Irwin DJ; Avants BB; Powers J; Cook PA; Toledo JB; McCarty Wood E; Van Deerlin VM; Lee VM; Trojanowski JQ; Grossman M
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):949-55. PubMed ID: 23475817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
    Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
    Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of p62/SQSTM1 antibodies for neuropathological diagnosis.
    Kuusisto E; Kauppinen T; Alafuzoff I
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):169-80. PubMed ID: 17961133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions.
    Tanji K; Zhang HX; Mori F; Kakita A; Takahashi H; Wakabayashi K
    J Neurosci Res; 2012 Oct; 90(10):2034-42. PubMed ID: 22674379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
    Geser F; Lee VM; Trojanowski JQ
    Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects.
    Halliday G; Bigio EH; Cairns NJ; Neumann M; Mackenzie IR; Mann DM
    Acta Neuropathol; 2012 Sep; 124(3):373-82. PubMed ID: 22878865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD.
    Roeber S; Mackenzie IR; Kretzschmar HA; Neumann M
    Acta Neuropathol; 2008 Aug; 116(2):147-57. PubMed ID: 18536926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration.
    Zhu J; Wang N; Li X; Zheng X; Zhao J; Xia H; Mao Q
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1124-1129. PubMed ID: 31626287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
    Foulds PG; Davidson Y; Mishra M; Hobson DJ; Humphreys KM; Taylor M; Johnson N; Weintraub S; Akiyama H; Arai T; Hasegawa M; Bigio EH; Benson FE; Allsop D; Mann DM
    Acta Neuropathol; 2009 Nov; 118(5):647-58. PubMed ID: 19823856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of TDP-43 Pathology in Hippocampal Synaptic Relays Suggests Transsynaptic Propagation in Frontotemporal Lobar Degeneration.
    Jamshidi P; Kim G; Shahidehpour RK; Bolbolan K; Gefen T; Bigio EH; Mesulam MM; Geula C
    J Neuropathol Exp Neurol; 2020 Jun; 79(6):585-591. PubMed ID: 32388566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
    Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
    Neumann M; Kwong LK; Truax AC; Vanmassenhove B; Kretzschmar HA; Van Deerlin VM; Clark CM; Grossman M; Miller BL; Trojanowski JQ; Lee VM
    J Neuropathol Exp Neurol; 2007 Mar; 66(3):177-83. PubMed ID: 17356379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.